|
Volumn 5, Issue , 2010, Pages 375-385
|
Development and implementation of treadmill exercise testing protocols in COPD.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRONCHODILATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
SCOPOLAMINE DERIVATIVE;
TIOTROPIUM BROMIDE;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EXERCISE TEST;
EXERCISE TOLERANCE;
FEASIBILITY STUDY;
FEMALE;
FORCED EXPIRATORY VOLUME;
GERMANY;
HOSPITALIZATION;
HUMAN;
LUNG;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PILOT STUDY;
PREDICTIVE VALUE;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
VITAL CAPACITY;
AGED;
BRONCHODILATOR AGENTS;
CHOLINERGIC ANTAGONISTS;
EXERCISE TEST;
EXERCISE TOLERANCE;
FEASIBILITY STUDIES;
FEMALE;
FORCED EXPIRATORY VOLUME;
GERMANY;
HUMANS;
LOS ANGELES;
LUNG;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
PREDICTIVE VALUE OF TESTS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
SCOPOLAMINE DERIVATIVES;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
VITAL CAPACITY;
MLCS;
MLOWN;
|
EID: 79952279089
PISSN: None
EISSN: 11782005
Source Type: Journal
DOI: 10.2147/copd.s11153 Document Type: Article |
Times cited : (24)
|
References (0)
|